TCL Archive Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products. April 22, 2005
TCL Archive Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival April 27, 2012